A Center Based Early Intervention Program for Preschoolers with Developmental Disorders
Launched by STANFORD UNIVERSITY · Jul 17, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a 12-week early intervention program designed to help preschoolers with developmental disorders, such as Autism Spectrum Disorder, improve their social communication skills. The program offers 12 hours each week of intensive support either at a specialized preschool or in the child's home. The goal is to see how effective this approach is in helping young children who may have difficulties with communication and social interactions.
To be eligible for the study, children must be between 2 and 5 years old and have a diagnosed developmental disorder like Autism or an intellectual disability. The program is open to all boys and girls who can participate in the activities. However, children with severe psychiatric disorders or those who cannot attend the program during its scheduled hours will not be included. Families who join the study can expect a structured and supportive environment aimed at enhancing their child's communication skills over the course of the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Developmental Disorder, such as Autism Spectrum Disorder, neurogenetic disorder, or intellectual disability, based on clinical interview;
- • Boys and girls between 2.0 years and 5.11 years at time of enrollment;
- • Ability to participate in the testing procedures to the extent that valid standard scores can be obtained.
- Exclusion Criteria:
- • Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.);
- • Lack of availability during program hours.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Antonio Hardan, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials